Corbus Pharmaceuticals Holdings, Inc. (LON: 0SZI)
London
· Delayed Price · Currency is GBP · Price in USD
11.41
-0.90 (-7.31%)
At close: Jan 22, 2025
Corbus Pharmaceuticals Holdings Employees
Corbus Pharmaceuticals Holdings had 19 employees as of December 30, 2023. The number of employees decreased by 14 or -42.42% compared to the previous year.
Employees
19
Change (1Y)
-14
Growth (1Y)
-42.42%
Revenue / Employee
n/a
Profits / Employee
-1.52M GBP
Market Cap
112.24M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
ConvaTec Group | 10,136 |
Hikma Pharmaceuticals | 9,100 |
HUTCHMED (China) | 1,988 |
Oxford Nanopore Technologies | 1,238 |
Corbus Pharmaceuticals Holdings News
- 17 days ago - Corbus Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Corbus Pharmaceuticals Announces Dosing of First Patient in its First-In-Human Study of CRB-601 to Treat Patients with Advanced Solid Tumors - GlobeNewsWire
- 7 weeks ago - FDA Grants Fast Track Designation to CRB-701 for the Treatment of Relapsed or Refractory Metastatic Cervical Cancer - GlobeNewsWire
- 2 months ago - Corbus Pharmaceuticals' Sell-Off: Speculative Entry Price In Oncology And Obesity Therapies - Seeking Alpha
- 3 months ago - Corbus Pharmaceuticals to Present at the Guggenheim Securities Healthcare Innovation Conference - GlobeNewsWire
- 3 months ago - Corbus Announces Enrollment Completion of Dose Escalation Stage of Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC (CRB-701) - GlobeNewsWire
- 4 months ago - Corbus Pharmaceuticals to Participate in the BMO Capital Markets' Oncology Summit - GlobeNewsWire
- 4 months ago - Nasdaq-Traded Cannabinoid Biotech Corbus Pharma Stock Plunges 60%, But Analysts Say 'Buy The Dip' Now - Benzinga